Page last updated: 2024-10-23

baclofen and Polymyositis

baclofen has been researched along with Polymyositis in 1 studies

Polymyositis: Diseases characterized by inflammation involving multiple muscles. This may occur as an acute or chronic condition associated with medication toxicity (DRUG TOXICITY); CONNECTIVE TISSUE DISEASES; infections; malignant NEOPLASMS; and other disorders. The term polymyositis is frequently used to refer to a specific clinical entity characterized by subacute or slowly progressing symmetrical weakness primarily affecting the proximal limb and trunk muscles. The illness may occur at any age, but is most frequent in the fourth to sixth decade of life. Weakness of pharyngeal and laryngeal muscles, interstitial lung disease, and inflammation of the myocardium may also occur. Muscle biopsy reveals widespread destruction of segments of muscle fibers and an inflammatory cellular response. (Adams et al., Principles of Neurology, 6th ed, pp1404-9)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Harmer, JP1
Larson, BS1

Other Studies

1 other study available for baclofen and Polymyositis

ArticleYear
Pain relief from baclofen analgesia in a neuropathic pain patient who failed opioid and pharmacotherapy: case report.
    Journal of pain & palliative care pharmacotherapy, 2002, Volume: 16, Issue:3

    Topics: Analgesics, Opioid; Baclofen; Female; Humans; Injections, Spinal; Middle Aged; Muscle Relaxants, Cen

2002